Northwestern just announced it's moving to 4 (with exceptions for "essential"
research) starting tomorrow at 5:00 PM and lasting 2 weeks.
On 3/19/20, 7:37 AM, "Core Administrators Network Forum on behalf of Stephen
Byers" <email obscured> on behalf of <email obscured>> wrote:
Georgetown has also moved to critical research activities. Basically we are
3-4
On Thu, Mar 19, 2020, 8:17 AM Stein, Annabelle
<email obscured>>
wrote:
> UNC CH has just moved to critical research activities only:
>
> For purposes of lab-based research, critical research activities are
> defined as either
> (1.) Activities that are directly related to COVID-19 or,
> (2.) Activities that: (a.) would be impossible to restart; (b.)
> could not be restarted without a significant investment of time; (c.)
would
> require significant financial resources to be restarted, or (d.)
represent
> extremely time-sensitive and critical graduate student experiments
required
> to ensure graduation during this calendar year.
> Any lab-based research or core activity that does not meet the definition
> provided above should be ramped down, curtailed, suspended, or delayed as
> expeditiously as possible.
>
>
>
>
> Annabelle Stein
> Associate Director, Office of Research Technologies
> University of North Carolina Chapel Hill
> CB #7064, Brinkhous-Bullitt Bldg
> 919-843-9554
> Visit our website at
https://urldefense.com/v3/__http://www.med.unc.edu/corefacilities__;!!Dq0X2DkFhyF93HkjWTBQKhk!A9zgrY3LvraSWW9YZvPfwyNdSRMkxAJOjlukdtE7-V0UO2DkCYTXHah-EaKISWbtukTeNiWrKw$
>
> -----Original Message-----
> From: Core Administrators Network Forum <email obscured>> On Behalf
> Of Madore,Steven
> Sent: Wednesday, March 18, 2020 5:06 PM
> To: <email obscured>
> Subject: Re: [core administrators network forum] OHSU Guidelines for
> COVID19 research activities
>
> We at ICBR at the University of Florida are just beginning to implement
> Level 2.
>
> Steve
>
>
> Steven J. Madore, Ph.D.
>
> Associate Director for Science
> UF ICBR
> 2033 Mowry Road, Gainesville, FL 32610
> Biotech.ufl.edu | Tel: 352.273.8038| Fax: 352.273.8070
>
>
> Associate Director of Shared Resources
> UF Cancer & Genetics Research Complex
> 2033 Mowry Road, Suite 145, Gainesville, FL 32610
https://urldefense.com/v3/__http://cancer.ufl.edu/__;!!Dq0X2DkFhyF93HkjWTBQKhk!A9zgrY3LvraSWW9YZvPfwyNdSRMkxAJOjlukdtE7-V0UO2DkCYTXHah-EaKISWbtukSpRUEyUw$
> | Tel: 352-273-8010
>
>
>
>
> -----Original Message-----
> From: Core Administrators Network Forum <email obscured>> On Behalf
> Of Richards, Heather
> Sent: Wednesday, March 18, 2020 4:59 PM
> To: <email obscured>
> Subject: Re: [core administrators network forum] OHSU Guidelines for
> COVID19 research activities
>
> [External Email]
>
> We at Ohio State are at a Level 2, with the potential for moving to 3 by
> the weekend very quickly. I would imagine a level 4 by the end of next
week.
>
> Thanks!
> Heather
>
> Heather Richards, MHA
> Administrative Manager of Shared Resources
> Phone: 614-293-8012 | Fax: 614-293-3305
> Website: go.osu.edu/sharedresources
>
> Please remember to cite the Shared Resources!
> Research reported in this publication was supported by The Ohio State
> University Comprehensive Cancer Center and the National Institutes of
> Health under grant number P30 CA016058.
> We thank the XX Shared Resource at The Ohio State University
Comprehensive
> Cancer Center, Columbus, OH for (XX).
>
> -----Original Message-----
> From: Core Administrators Network Forum <email obscured>> On Behalf
> Of Thomas Colella
> Sent: Wednesday, March 18, 2020 4:57 PM
> To: <email obscured>
> Subject: Re: [core administrators network forum] OHSU Guidelines for
> COVID19 research activities
>
> CAUTION: External Email
>
> Thank you, Andy. For awareness, ASU is currently operating at the
> equivalent of OHSU's Level 1, with the addition of limited access to
> buildings.
>
> To inform discussions with university leadership, it would be helpful to
> know where other institutions are currently operating, and to hear status
> updates as they occur.
>
> Anyone care to share their status?
>
> Tom Colella
> Executive Director, Knowledge Enterprise Operations Arizona State
> University t 480.965.6298 | f 480.965.9811 <email obscured>
>
> -----Original Message-----
> From: Core Administrators Network Forum <email obscured>> On Behalf
> Of chitty
> Sent: Wednesday, March 18, 2020 10:29 AM
> To: <email obscured>
> Subject: [core administrators network forum] OHSU Guidelines for COVID19
> research activities
>
> Just to let folks know how OHSU is handling operations, in case you want
> to compare:
>
> With the ongoing COVID-19 pandemic, we are defining five levels of
> responsiveness that laboratories at OHSU will be required to adhere to.
Our
> goals are to keep our research community safe and healthy, support
research
> on the SARS-CoV-2 virus and its accompanying COVID-19 disease, practice
the
> necessary social distancing required to minimize coronavirus spread in
the
> community, and most importantly, to reduce the impact of research
> operations on the functioning of the healthcare mission.
>
> As of today (3/17/20), we are at Level 1. When modified operations begin
> on Monday, we will be at Level 2. I fully expect OHSU to move to Level 3
> immediately, and you should be prepared for us to move to Level 4 as
early
> as the middle or end of next week. Note that multiple triggers may
catalyze
> the transition to Level 3 or Level 4, for example a significant depletion
> of DCM staff (e.g., from child-care responsibilities or illness).
>
> These actions are consistent with what our colleagues are doing at other
> institutions, especially those affiliated with hospitals. Note that this
> communication is focused on laboratory research, not clinical research.
> Clinical research has been addressed in this document.
>
> If you have not done so, you should plan for how you will curtail lab
> operations and eventually shut them down. See the two sample plans: a
blank
> one courtesy of UCSF and the plan created by my lab.
>
> This is a living policy that will evolve as conditions change. Stay safe.
>
>
> Levels of Research Operations
>
> Level 0
> Normal operations
>
> Level 1
> Teleworking encouraged
> Social distancing required
>
> Level 2
> Lab research shutdown plan reviewed and approved by chair or director by
> Thursday, March 19 (we will provide a fillable form within a few days,
but
> please do not wait for that) No new experiments Essential experiments
> allowed—those that, if discontinued, would generate significant financial
> or data loss No more than 3 lab members designated as critical staff;
> rotations allowed Students should not be working in the lab (this policy
is
> under reconsideration) All research buildings will be locked Maintenance
of
> key resources—animals, cell lines, liquid N2, etc.
> Separate policies for nonhuman primate research Separate policies for
> COVID-19 research
>
> Level 3
> ALL experiments stopped
> Revised lab research shutdown plan reviewed and approved by chair or
> director within 24 hours of announcement of transition to Level 3 (we
will
> provide a fillable form within a few days, but please do not wait for
that)
> Research action plan filed with OHSU Research & Innovation within 24
hours
> of announcement of transition to Level 3 (we will provide a link for
filing
> in the next 48 hours) All research buildings will be locked No more than
2
> lab members designated as critical staff; rotations allowed ONLY in cases
> of emergency with department approval and notification of OHSU Research &
> Innovation One person per lab allowed on campus at any given time Lab
staff
> must freely volunteer to come to OHSU—no coercion allowed Building access
> may be restricted, so expect that only designated critical staff will be
> allowed in Key resource maintenance allowed—animals, cell lines, liquid
N2,
> etc.
> Mandatory reduction of rodent colony size (see message from Kim Saunders
> on 3/16/20; further guidance will be coming) For those labs with large
> rodent colonies, depletion of DCM staff may require those labs to assist
in
> animal care Separate policies for nonhuman primate research Separate
> policies for COVID-19 research ALL exceptions reviewed and approved by
OHSU
> Research & Innovation
>
> Level 4
> NO LAB STAFF OR PI BUILDING ACCESS AT ALL Revised lab research shutdown
> plan reviewed and approved by chair or director within 24 hours of
> announcement of transition to Level 4 (we will provide a fillable form
> within a few days, but please do not wait for that) Liquid N2 maintenance
> ONLY by Research Stores—cannot be guaranteed, however (further messaging
> coming 3/18/20) Animal management ONLY by Department of Comparative
> Medicine (DCM) Exceptions only allowed for irreplaceable animals not
> managed by DCM (e.g., transgenic zebrafish, Drosophila lines) For
rodents,
> Gold Star-labeled cages will be prioritized but care cannot be guaranteed
> (further messaging coming 3/18/20) Mandatory reduction of rodent colony
> size Separate policies for nonhuman primate research Separate policies
for
> COVID-19 research ALL exceptions reviewed and approved by OHSU Research &
> Innovation (review process will be forthcoming) Animal exceptions
reviewed
> and approved by DCM (review process will be forthcoming) ―― View topic
>
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_2dOOk0vLopxElAh4HibnE0&d=DwIFaQ&c=l45AxH-kUV29SRQusp9vYR0n1GycN4_2jInuKy6zbqQ&r=vof_zydR8W2RsL5o90VLKbQSJpkyRvW0t4D9IVCM8HU&m=3QaQag958DhGHMcfS0Ul6pKnih7uStvyDYX1hmtvspY&s=pvD0hEHhs9a6jIgBi2I8m_4D7PImwkgS0HYdPpAK744&e=
> Leave group <email obscured>?Subject=Unsubscribe
>
>
> ――
> View topic
>
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_5aFEVGKJvcd1nQaIjDDbWG&d=DwIFaQ&c=k9MF1d71ITtkuJx-PdWme51dKbmfPEvxwt8SFEkBfs4&r=7l0aEz8iy5TWGjlvlBEBjEZw369-oj4Hd9_7ExbHAXI&m=nLWalvs6p9H3Ko5NepR4OAnlTnQP6Fl9SLsVTMNtkqI&s=Pl36e5oemrz0wuOE51QMuv6J6EsGcyL3G4J301mkvpY&e=
> Leave group <email obscured>?Subject=Unsubscribe
>
>
> ――
> View topic
>
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_5wzSLZx7j0RICcINHMo84j&d=DwIFaQ&c=sJ6xIWYx-zLMB3EPkvcnVg&r=SLc-lplkD2osTNL6qTLx1g&m=A7pFyUHwYFxvgrnQaIMZWhxQ9IAgETVadhnIFZQt8cA&s=-pbxukJmYVKeI7D48eLF_FdUGxV6TDYHpklVaUczmDg&e=
> Leave group <email obscured>?Subject=Unsubscribe
>
>
> ――
> View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/32jgPMPx7LzjPz6XLImtJr__;!!Dq0X2DkFhyF93HkjWTBQKhk!A9zgrY3LvraSWW9YZvPfwyNdSRMkxAJOjlukdtE7-V0UO2DkCYTXHah-EaKISWbtukT4VG2HLg$
> Leave group <email obscured>?Subject=Unsubscribe
>
>
> ――
> View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/3uUDUKtLWIxVNmel1Z63v__;!!Dq0X2DkFhyF93HkjWTBQKhk!A9zgrY3LvraSWW9YZvPfwyNdSRMkxAJOjlukdtE7-V0UO2DkCYTXHah-EaKISWbtukTgEECNPQ$
> Leave group <email obscured>?Subject=Unsubscribe
>
>
――
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/6NxnvoxblvYzniabpKTooQ__;!!Dq0X2DkFhyF93HkjWTBQKhk!A9zgrY3LvraSWW9YZvPfwyNdSRMkxAJOjlukdtE7-V0UO2DkCYTXHah-EaKISWbtukRB23tm8g$
Leave group <email obscured>?Subject=Unsubscribe